Calumet Specialty Products Partners LP (CLMT) stock suffered a 5.2% pre-market plunge on Tuesday, following a downgrade by analysts at TD Cowen.
According to reports, TD Cowen lowered its rating on CLMT from "Buy" to "Hold" and cut the price target from $26 to $22.80. This negative analyst action appears to be the primary driver behind CLMT's steep pre-market decline.
Analysts at other firms currently have an average "Overweight" rating on CLMT shares, with a mean price target of $22.80, according to data compiled by FactSet. However, the downgrade from TD Cowen, a respected Wall Street research firm, has likely weighed heavily on investor sentiment, leading to the sell-off in pre-market trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.